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Estrogen is reported to prevent age-associated epidermal thinning in the skin. We examined if 17b-estradiol (E2)
may enhance the growth of human keratinocytes, focusing on its effects on the expression of cell cycle-regulatory
proteins. E2 enhanced proliferation, bromodeoxyuridine incorporation of keratinocytes, and increased the
proportion of cells in the S phase. The E2-induced stimulation of proliferation and bromodeoxyuridine
incorporation was suppressed by antisense oligonucleotide against cyclin D2, which induces G1 to S phase
progression. E2 increased protein and mRNA levels of cyclin D2, and resultantly enhanced assembly and kinase
activities of cyclin D2-cyclin-dependent kinases 4 or 6 complexes. E2 enhanced cyclin D2 promoter activity, and the
element homologous to cAMP response element (CRE) on the promoter was responsible for the effect. Cyclin D2
expression was enhanced by antiestrogens, ICI 182,780 and 4-hydroxytamoxifen, and membrane-impermeable
bovine serum albumin-conjugated E2, indicating the effects via membrane E2-binding sites. E2 increased the
enhancer activity of CRE-like element and the amount of phosphorylated cAMP response element binding protein
(CREB) binding this element, and the increases were suppressed by H-89, an inhibitor of cAMP-dependent protein
kinase A. H-89 also suppressed E2-induced cyclin D2 expression, proliferation, and bromodeoxyuridine
incorporation in keratinocytes. Antisense oligonucleotide against G-protein-coupled receptor GPR30 suppressed
the E2-induced increases of phosphorylated CREB, cyclin D2 level, proliferation, and bromodeoxyuridine
incorporation in keratinocytes. These results suggest that E2 may stimulate the growth of keratinocytes by
inducing cyclin D2 expression via CREB phosphorylation by protein kinase A, dependent on cAMP. These effects
of E2 may be mediated via cell surface GPR30.
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Epidermal thinning in the skin proceeds with increasing age
(Varani et al, 1998). This may be caused by the age-
associated accumulation of replicative senescent keratino-
cytes arrested in the G1 phase of the cell cycle (Dimri et al,
1995). The transition from the G1 to S phase is promoted by
D-type cyclins (Campisi, 1998; Chung et al, 2000). In the
mid to late G1 phase, D-type cyclins, cyclin D1, D2, or D3
associate with cyclin-dependent kinase 4 (Cdk4) or Cdk6,
and induce these kinases to phosphorylate retinoblastoma
tumor suppressor protein (pRb) (Gao and Zelenka, 1997).
Phosphorylation of pRb disrupts the inhibitory complexes
preformed between pRb and E2F family transcription
factors, permitting E2F-dependent transcription of genes
required for DNA replication, such as thymidylate synthe-
tase, thymidine kinase, or DNA polymerase a (Campisi,
1998). On the other hand, p21cip1, p27kip1, or p16INK4A bind
and inactivate Cdks and thus suppress the cell cycle
progression (Gao and Zelenka, 1997; Campisi, 1998).
Among three D-type cyclins, cyclin D2 mainly acts as a
G1/S progressor in the skin (Chung et al, 2000). It is reported
that cyclin D2 expression is reduced in the aged skin
(Chung et al, 2000), whereas the expression of Cdk
inhibitors is increased in senescent keratinocytes (Sayama
et al, 1999; Chaturvedi et al, 1999).
It has been reported that estrogen prevents or delays
age-associated changes in the skin (Shah and Maibach,
2001). Topical application of estrogen suppressed epider-
mal thinning in the aged skin (Goldzieher, 1946; Eller and
Eller, 1949) and maintained skin thickness (Shah and
Maibach, 2001; Sator et al, 2001). Previous study reported
that 17b-estradiol (E2) in vitro stimulated proliferation and
DNA synthesis of human keratinocytes (Urano et al, 1995),
which may be related to the in vivo effects of E2 to prevent
epidermal atrophy. But the precise mechanism for the
growth-stimulatory effects of E2 is not identified, including
the relation to the expression of cell cycle stimulators or
inhibitors. It is known that E2 exerts its effects by two
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different mechanisms, genomic or non-genomic, and E2
may promote the growth of keratinocytes by either or both
mechanisms. The genomic mechanism is that E2-bound
nuclear estrogen receptor (ER) a or b simulates or inhibits
gene expression by binding to estrogen response element
of the target genes or by interacting with other transcription
factors (Beato, 1989; Kanda and Watanabe, 2003a). On the
other hand, the non-genomic mechanism is that E2
interacts with cell surface binding sites and rapidly induces
a variety of intracellular signals (Kelly and Levin, 2001), such
as activation of adenylate cyclase (AC) (Aronica et al, 1994),
phospholipase C (Razandi et al, 1999), or extracellular
signal-regulated kinase (ERK) (Migliaccio et al, 1996).
Membrane estrogen-binding sites do not appear to be a
unique molecule; some may be post-translationally mod-
ified forms of nuclear ERa or b, and others may be
structurally different from nuclear ERs (Papas et al, 1995;
Razandi et al, 1999; Benten et al, 2001). It is reported that
estrogen can interact with several G-protein-coupled
receptors like steroid hormone-binding globulin receptor
(Fissore et al, 1994), or an orphan receptor GPR30 (Filardo
et al, 2002).
In this study, we examined the in vitro effects of E2 on the
proliferation and DNA synthesis of human keratinocytes. We
found the stimulatory effects of E2. We further analyzed the
mechanism for the effects of E2, focusing on the expression
of cell cycle regulatory proteins.
Results
E2 stimulated the growth of keratinocytes E2 stimulated
keratinocyte proliferation (Fig 1a) and BrdU incorporation
(Fig 1b) in parallel; the stimulatory effect of E2 was
concentration-dependent, and was maximized at 108 M,
which increased the cell number 3.1-fold and BrdU
incorporation 3.5-fold of controls, respectively. E2 stereo-
isomer 17a-estradiol did not stimulate proliferation or BrdU
incorporation of keratinocytes. E2-BSA, membrane-im-
permeable bovine serum albumin-conjugated E2, increased
the keratinocyte proliferation and BrdU incorporation with
107 M of optimal concentration, indicating that the effect of
E2 may be exerted via membrane E2-binding sites.
Antiestrogens, ICI 182,780 and 4-hydroxytamoxifen stimu-
lated the keratinocyte proliferation and BrdU incorporation
with 107 M of optimal concentration. The addition of these
antiestrogens did not suppress the E2-induced increases in
proliferation and BrdU incorporation (data not shown). Thus
E2, E2-BSA, and antiestrogens stimulated the proliferation
and BrdU incorporation in keratinocytes, and the effects
appeared to occur at the membrane. These results indicate
that E2 may induce G1/S transition of cell cycle since BrdU
is incorporated into newly synthesized DNA of S phase
cells. We then performed cell cycle analysis, and found that
E2 increased the proportion of S phase cells and decreased
that of G0/G1 phase (Fig 2), indicating the G1/S transition by
E2. E2-BSA, 4-hydroxytamoxifen, and ICI 182,780 also
increased the percentage of S phase and decreased that of
the G0/G1 phase (data not shown). Since D-type cyclins are
required for G1/S transition whereas Cdk inhibitors sup-
press the actions of these cyclins, we then analyzed the
effects of E2 on the expression of these cell cycle
regulators.
E2 increased cyclin D2 protein and mRNA levels and
induced assembly and activation of cyclin D2-Cdk4 or 6
complexes E2, E2-BSA, ICI 182,780, and 4-hydroxyta-
moxifen increased cyclin D2 mRNA (Fig 3a) and protein
levels (Fig 3b) in keratinocytes, whereas these were not
altered by 17a-estradiol or bovine serum albumin. The
addition of ICI 182,780 or 4-hydroxytamoxifen did not
suppress the effects of E2 on the cyclin D2 levels (data not
shown). On the other hand, E2, E2-BSA, antiestrogens did
not alter the mRNA (Fig 3a) and protein levels (data not
shown) of cyclin D1, cyclin D3, or Cdk inhibitors p27kip1,
p21cip1, or p16INK4A. Thus E2, E2-BSA, and antiestrogens
selectively increased cyclin D2 levels. The correlation of
growth with cyclin D2 level indicates that the increase of
Figure1
Dose dependency for the effects of E2, E2-BSA, and antiestrogens
on proliferation (a) and BrdU incorporation (b). (a) Keratinocytes
seeded in 24-well plates were starved for 18 h, then incubated with
indicated concentrations of E2, ICI 182,780 (ICI), 4-hydroxytamoxifen
(4OHT), E2-BSA, bovine serum albumin (BSA), or 17a-estradiol (17a-
E2). After 4 d, the cell number was counted. Values are mean  SD of
triplicate cultures. (b) Keratinocytes seeded in 96-well plates were
starved for 18 h, and incubated with indicated concentrations of
hormones for 20 h. The cells were pulsed with BrdU for 4 h, then
BrdU incorporation was analyzed by ELISA. Values are mean  SD of
triplicate cultures. po0.05 versus controls by one-way ANOVA with
Dunnett’s multiple comparison test. The data shown in the figures are
representative of five separate experiments.
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cyclin D2 may be responsible for the growth-stimulation by
E2. This is supported by the experiment using antisense
oligonucleotides; antisense cyclin D2 suppressed constitu-
tive and E2-induced growth of keratinocytes (Fig 4).
Since cyclin D2 associates with Cdk4 or Cdk6 and
enhances pRb phosphorylation by these Cdks (Fujita et al,
2002); we examined if E2 may increase the assembly of
cyclin D2 with Cdk4 or 6. E2 increased the amounts of
cyclin D2-Cdk4 or 6 complexes in keratinocytes, whereas
did not increase those of cyclin D3-Cdk4 or 6 complexes
(Fig 5a). We next analyzed Cdk4 or 6-dependent kinase
activities in keratinocytes. E2 enhanced the pRb-phosphor-
ylating activities of immunoprecipitates with anti-cyclin D2,
Cdk4, or Cdk6 antibodies, whereas it did not enhance that
of anti-cyclin D3 immunoprecipitate (Fig 5b). These results
suggest that E2 may promote the assembly of cyclin D2-
Cdk4 or 6 complexes and enhance Cdk4 or 6 kinase
activities. E2-BSA, 4-hydroxytamoxifen, and ICI 182,780
also increased the assembly and kinase activities of cyclin
D2-Cdk4 or 6 complexes (data not shown). We then
examined if E2 may promote cyclin D2 promoter activity in
keratinocytes.
E2 enhanced cyclin D2 promoter activity We transiently
transfected full-length (1624/1 bp) or 50-deleted (444/
1 bp) cyclin D2 promoters linked to luciferase reporter
into keratinocytes, and the promoter activity was evaluated
by relative luciferase activity of the cell lysates. E2 increased
the activities of both full-length and 50-deleted promoters
to similar extents (Fig 6b, first and third two columns). E2-
BSA, ICI 182,780, and 4-hydroxytamoxifen enhanced both
promoter activities, whereas 17 a-estradiol did not increase
either promoter activity (data not shown). The full-length
cyclin D2 promoter contained E2F element and two NF-kB-
like elements (NF-kB1, NF-kB2) (Fig 6a). The mutation of
these three elements did not decrease the basal or E2-
induced promoter activities (Fig 6b, second two columns),
Figure 2
Effects of E2 on cell cycle distribution. Keratinocytes were incubated
with KBM alone (upper panel) or with 108 M E2 (lower panel) for 24 h,
then cell cycle distribution was analyzed by flow cytometric analysis of
DNA content. The results shown in the figure are representative of five
separate experiments.
Figure3
The effects of E2, E2-BSA, or antiestrogens on cyclin D2 mRNA (a)
and protein levels (b). Keratinocytes were incubated with KBM alone
or with 108 M E2, 107 M E2-BSA, 107 M ICI 182,780 (ICI), 107 M 4-
hydroxytamoxifen (4OHT), 107 M bovine serum albumin (BSA), or 108
M 17a-estradiol (17a-E2). After 3 h, total cellular RNAs or proteins were
isolated. The intensity of the band for cyclin D2 was corrected to that
for GAPDH, and the corrected intensities relative to that in control cells
(set as 1.0) are shown. The results shown in the figures are
representative of five separate experiments.
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indicating that these elements may be dispensable for basal
and E2-induced cyclin D2 promoter activities. 50-deletion of
cyclin D2 promoter at 444 bp lost these three upstream
elements, however, retained downstream element
(TTGCGTCA) related to consensus CRE (TGACGTCA) and
two NF-kB-like elements (NF-kB3, NF-kB4) (Fig 6a). The
mutation of NF-kB3 or NF-kB4 (Fig 6b, four columns at the
bottom) reduced the basal promoter activity by about 30%,
respectively, however, did not reduce the magnitude of
response to E2, indicating that these two elements may
partially confer the basal promoter activity, however, may be
dispensable for the E2-induced stimulation. In contrast, the
mutation of CRE-like element (Fig 6b, fourth two columns)
reduced the basal promoter activity by about 60% and
completely abolished E2-induced stimulation. These results
suggest that CRE-like element may confer the basal
promoter activity and may be responsible for the activation
by E2. Similar results on mutated promoters were obtained
using E2-BSA or antiestrogens in place of E2 (data not
shown). We then analyzed if E2 may promote enhancer
activity of the CRE-like element.
E2 increased the enhancer activity of CRE-like ele-
ment Keratinocytes were transiently transfected with luci-
ferase reporter linked to four repeats of the CRE-like
element in front of TATA box. E2 increased the enhancer
activity of CRE-like element (Fig 7). E2-BSA, ICI 182,780
and 4-hydroxytamoxifen increased the enhancer activity of
the CRE-like element, whereas 17a-estradiol did not. It is
known that the phosphorylation of transcription factor
CREB at Ser133 promotes its transcriptional activity at
CRE (Kwok et al, 1994). The phosphorylation of CREB
recruits transcriptional coactivator CREB binding protein
(CBP), which increases the interaction of CBP with basal
transcription factor TFIIB, and thus facilitates CREB-
mediated transcription. We then performed EMSA and
examined if E2 may enhance the phosphorylation of CREB
binding the CRE-like element.
Figure 4
Inhibition by cyclin D2 antisense oligonucleotide on E2-induced
stimulation of BrdU incorporation (a) and proliferation (b). Kerati-
nocytes were pretreated with 0.2 mM of indicated antisense oligonu-
cleotides (ASO) against cyclin D2 (CycD2) or control scrambled
oligonucleotides (Con) for 4 h. The cells were then incubated with
108 M E2. BrdU incorporation was analyzed at 24 h (a), and cell
number was counted after 4 d (b). Values are mean  SEM of five
separate experiments. po0.05 versus values with medium alone,
wpo0.05 versus values with E2 alone, by one-way ANOVA with
Scheffe’s multiple comparison test.
Figure6
Effects of E2 on wild type or mutated cyclin D2 promoters. (a)
Schematic representation of human cyclin D2 promoter. Possible
elements for E2F, CRE, and NF-kB are shown. The nucleotide positions
are relative to the translational start site. (b) Keratinocytes were
transiently transfected with wild type (WT) or mutated pCycD2-Luc
together with pCH110, and incubated with medium alone or with 108
M E2 for 5 h. Relative luciferase activities normalized to b-galactosi-
dase activities are shown. The data are mean  SEM (n¼ 4). Values at
right indicate the fold induction versus basal promoter activity. po0.05
versus controls, by paired t test.
Figure 5
E2-induced increase in assembly and activation of cyclin D2-Cdk4
or 6 complexes. Keratinocytes were incubated with KBM alone or with
108 M E2 for 3 h. (a) The cell extracts were immunoprecipitated with
antibody against Cdk4, or Cdk6 and immunoblotted with anti-cyclin D2
or anti-cyclin D3 antibodies. (b) In vitro kinase assay was performed on
immunoprecipitates with antibodies against cyclin D2, cyclin D3, Cdk4
or Cdk6 using GST-pRb as a substrate. The results shown in the figures
are representative of five separate experiments.
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E2 enhanced the phosphorylation of CREB binding the
CRE-like element, dependent on cAMP/protein kinase A
(PKA) pathway DNA–protein complex was obtained by the
incubation of keratinocyte nuclear extracts with the cyclin
D2 promoter-derived probe containing the CRE-like ele-
ment (Fig 8a, lanes 2 and 3). Anti-CREB antibody super-
shifted the complex (lanes 4 and 5), indicating the presence
of CREB in the complex. E2 did not increase the amount of
total CREB in the complex (lanes 4 and 5), however,
increased the amount of Ser133-phosphorylated CREB in
the complex (lanes 6 and 8). E2-BSA, ICI 182,780, and
4-hydroxytamoxifen also increased the amount of phos-
phorylated CREB without altering that of total CREB (data
not shown). These results indicate that CREB may
constitutively bind the CRE-like element, and that E2,
E2-BSA, and antiestrogens may enhance the phosphoryla-
tion of the bound CREB, which may promote the transcrip-
tion through this element. CREB is phosphorylated at Ser133
by a variety of serine/threonine kinases, dependent on the
stimuli or cell types, cAMP-dependent PKA, protein kinase
C, Akt, Ca2þ /calmodulin-dependent protein kinase type IV,
mitogen-activated protein kinase (MAPK)-activated protein
kinase-2, p70S6K or p90rsk (Tan et al, 1996). We then
analyzed which of the kinases may be responsible for
E2-induced CREB phosphorylation, using specific kinase
inhibitors. H-89, an inhibitor of PKA, reduced the amounts
of phosphorylated CREB both in the presence and absence
of E2 (lanes 7 and 9), indicating the involvement of cAMP/
PKA signaling pathway for constitutive and E2-induced
CREB phosphorylation. This is supported by the fact that
cAMP analog dibutyryl cAMP increased the amount of
phosphorylated CREB (lane 12). In parallel with the inhi-
bition of CREB phosphorylation, H-89 suppressed consti-
tutive and E2-induced enhancer activity of the CRE-like
element, whereas dibutyryl cAMP increased the enhancer
activity (Fig 8b). These results suggest that cAMP/PKA
pathway may be required for basal and E2-induced
enhancer activity of the CRE-like element via phosphoryla-
tion of CREB. In contrast, the E2-induced increases in
phosphorylated CREB and enhancer activity of the CRE-like
element were not suppressed by calphostin C, LY294002
(Fig 8), rapamycin, W-7, PD98059, or SB202190 (data not
shown), which inhibit protein kinase C, phosphatidylinositol-
3-OH kinase (PI-3K)/Akt signaling pathway, p70S6K, Ca2þ /
calmodulin-dependent protein kinase type IV, ERK kinase 1/
ERK/p90rsk pathway, or p38 MAPK/MAPK-activated protein
kinase-2 pathway, respectively. These indicate that the E2-
induced CREB phosphorylation may not involve protein
kinase C, Akt, Ca2þ /calmodulin-dependent protein kinase
type IV, MAPK-activated protein kinase-2, p70S6K, or p90rsk.
These inhibitors did not suppress the basal enhancer
activity of the CRE-like element (Fig 8b) or constitutive
CREB phosphorylation (data not shown).
Figure 7
Effects of E2, E2-BSA, or antiestrogens on enhancer activity of
CRE-like element. Keratinocytes were transiently transfected with
p4xCRE-TATA-Luc or enhancerless pTATA-Luc together with pCH110.
The cells were incubated with medium alone or with 108 M E2, 107 M
E2-BSA, 107 M ICI 182,780 (ICI), 107 M 4-hydroxytamoxifen (4OHT),
107 M bovine serum albumin (BSA), or 108 M 17a-estradiol (17a-E2)
for 5 h. The results are shown as relative luciferase activities normalized
to b-galactosidase activities, and represent mean  SEM (n¼ 4).
Values at right indicate the fold induction versus basal promoter
activity. po0.05 versus values with medium alone, by one-way
ANOVA with Scheffe’s multiple comparison test.
Figure8
Effects of E2 or signal modulators on DNA binding of total or phos-
phorylated CREB (a) and enhancer activity of CRE-like element (b).
(a) Keratinocytes were preincubated with 1 mM H-89, 1 mM calphostin C
(CalC), or 10 mM LY294002 (LY) for 10 min, then incubated with KBM
alone or with 108 M E2 or 1 mM dibutyryl cAMP (Bt2cAMP). After 1 h,
nuclear extracts were prepared. The nuclear extracts were incubated
with 32P-labeled oligonucleotides containing CRE-like element from
cyclin D2 promoter. In supershift assays, antibodies against total CREB
(C) or phosphorylated CREB (P) were incubated for 30 min before the
addition of the probe. Arrows indicate the DNA–protein complexes and
supershifted complexes. The results shown in the figure are represen-
tative of five separate experiments. (b) Keratinocytes were transiently
transfected with p4xCRE-TATA-Luc together with pCH110. The cells
were preincubated with signal inhibitors, then incubated with E2 or
Bt2cAMP as described above for 5 h. The results are shown as relative
luciferase activities normalized to b-galactosidase activities, and
represent mean  SEM (n¼4). po0.05 versus values with medium
alone, and wpo0.05 versus values with E2 alone, by one-way ANOVA
with Scheffe’s multiple comparison test.
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E2-induced cyclin D2 expression and growth-stimula-
tion were dependent on cAMP/PKA pathway We then
analyzed if E2-induced cyclin D2 expression and growth-
stimulation may be suppressed by PKA inhibitor. H-89
suppressed both constitutive and E2-induced cyclin D2
promoter activity (Fig 9a), cyclin D2 protein expression (Fig
9d), BrdU incorporation (Fig 9b), and proliferation (Fig 9c). In
parallel with the inhibition of cyclin D2 expression, H-89
inhibited constitutive and E2-induced assembly of cyclin D2
with Cdk4 (Fig 9e) or Cdk6 (data not shown) and pRb-
phosphorylating activities of immunoprecipitates with anti-
cyclin D2, Cdk4 (Fig 9f), or Cdk6 antibodies (data not
shown). H-89 also inhibited the cyclin D2 expression and
growth-stimulation induced by E2-BSA, ICI 182,780, or 4-
hydroxytamoxifen (data not shown). On the other hand,
dibutyryl cAMP enhanced cyclin D2 expression, assembly
and kinase activities of cyclin D2-Cdk4 complex, and
growth in keratinocytes (Fig 9). These results indicate that
cAMP/PKA signaling pathway may be required for basal
and E2-induced cyclin D2 expression and activity to
promote DNA synthesis and proliferation.
Antisense GPR30 suppressed E2-induced CREB phos-
phorylation and cyclin D2 expression Since membrane-
impermeable E2-BSA induced cyclin D2 expression depen-
dent on PKA, E2 may act on the cell surface of
keratinocytes and may activate cAMP/PKA pathway. We
also recently found that E2, E2-BSA, and antiestrogens
increased intracellular cAMP level in human keratinocytes
by activating AC (Kanda and Watanabe, 2003b). The
induced cAMP may bind to PKA regulatory subunits, which
may release and activate PKA catalytic subunits precom-
plexed with the regulatory subunits. It is reported that
E2-induced cAMP signal is mediated via membrane-
localized ERa, ERb (Razandi et al, 1999), or GPR30 (Filardo
et al, 2002). We have detected ERb and GPR30 mRNAs, but
not that of ERa in keratinocytes by RT-PCR (Kanda and
Watanabe, 2003b, 2003d). This indicates that ERa or
GPR30 localized at the membrane may mediate the
E2-induced cAMP signal and CREB phosphorylation in
keratinocytes. Since specific antibody against GPR30
cannot be obtained, we analyzed if ERb or GPR30 antisense
oligonucleotides may inhibit E2-induced CREB phosphor-
ylation. GPR30 antisense did but ERb antisense did not
suppress the E2-induced increases in phosphorylated
CREB (Fig 10a), cyclin D2 level (Fig 10b), BrdU incorpora-
tion (Fig 10c), and proliferation (Fig 10d). E2-BSA, ICI
182,780, or 4-hydroxytamoxifen-induced CREB phosphor-
ylation, cyclin D2 expression, and growth-stimulation were
also suppressed by GPR30 antisense but not by ERb
antisense (data not shown). These results suggest that cell
surface GPR30 may mediate the E2, E2-BSA, and anti-
estrogen-induced CREB phosphorylation, cyclin D2 expres-
sion, and growth-stimulation, whereas ERb may not be
involved in these effects.
Discussion
In this study, E2 enhanced the growth of keratinocytes
by inducing cyclin D2 expression. The induced cyclin D2
associated with Cdk4 or 6 and enhanced their pRb-
phosphorylating activity. The pRb phosphorylation may
release and activate E2F prebound by pRb, and promote
the E2F-dependent transcription of genes required for DNA
replication (Gao and Zelenka, 1997). The E2-induced cyclin
D2 transcription was mediated via CREB phosphorylation
by cAMP-dependent PKA. Previous study also reported
that E2 induced cAMP signal, CREB phosphorylation, and
CREB-dependent neurotensin gene expression in neuronal
SK-N-SH cells (Watters and Dorsa, 1998). It is reported that
cAMP-elevating agents promote cyclin D2 expression and
enhance the growth of rat or mouse ovarian granulosa cells
(Sicinski et al, 1996; Robker and Richards, 1998). In these
studies, however, the precise mechanism for cAMP-
induced cyclin D2 expression is not shown. This study
elucidated that CRE-like element (294/287 bp) on cyclin
D2 promoter may act as a cAMP-inducible element. This
element also acted as an enhancer element for cyclin D2
transcription induced by HTLV-I oncogene product Tax
in human T cells (Huang et al, 2001). In Tax-induced
transcription, however, the cooperation with NF-kB3 (131/
121 bp) was required for the CRE-like element to be
functional. On the other hand, the CRE-like element
appeared to act independently of NF-kB3 in E2-stimulated
keratinocytes (Fig 6). This difference indicates that cyclin D2
expression is distinctly regulated dependent on the stimuli or
cell types.
E2 appeared to induce cAMP/PKA pathway in keratino-
cytes via membrane G-protein-coupled receptor, GPR30.
Figure 9
Inhibition by PKA inhibitor on E2-induced increases in cyclin D2
promoter activity (a), BrdU incorporation (b), proliferation (c), cyclin
D2 protein level (d), assembly (e), and kinase activities (f) of cyclin
D2-Cdk4 complex. (a) Keratinocytes were transiently transfected with
pCycD2-Luc together with pCH110, and preincubated with 1 mM H-89
for 10 min, then incubated with KBM alone, or 108 M E2 or 1 mM
dibutyryl cAMP (Bt2cAMP) for another 5 h. Luciferase activities of the
cell lysates were analyzed and were normalized to b-galactosidase
activities. (b–f) Keratinocytes without transfection were incubated as
above. BrdU incorporation was analyzed after 24 h (b), cell number was
counted after 4 d (c), and cell extracts were obtained after 3 h (d–f). The
cell extracts were immunoblotted with anti-cyclin D2 antibody (d), or
immunoprecipitated with anti-Cdk4 antibody, then immunoblotted with
anti-cyclin D2 antibody (e). In vitro kinase assay was performed on
immunoprecipitates with antibodies against cyclin D2 or Cdk4 using
GST-pRb as a substrate (f). In (a–c), values are mean  SEM of five
separate experiments. po0.05 versus values with medium alone,
wpo0.05 versus values with E2 alone, by one-way ANOVA with
Scheffe’s multiple comparison test. The results shown in (d–f) are
representative of five separate experiments.
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Previous study also reported that E2 generated cAMP
signal via GPR30 in breast cancer cells (Filardo et al, 2002)
and macrophages (Kanda and Watanabe, 2003c). In these
studies, tamoxifen derivatives or ICI compounds induced
cAMP signal, whereas 17a-estradiol did not. These are
consistent with our present results, and indicate that
tamoxifen derivatives or ICI compounds may act as
agonists for GPR30, whereas 17a-estradiol may not.
Besides E2 generated cAMP signal independently of ERb
in the previous (Filardo et al, 2002; Kanda and Watanabe,
2003c) and in these studies (Fig 10). Since activation of
GPR30 induced cAMP signal, GPR30 may possibly be
linked to AC via Gs. It is hypothesized that the binding of E2
may activate GPR30 and induce the dissociation of the
receptor-coupled G-protein heterotrimers, possibly Gsabg,
into Gsa and Gbg, the former of which may stimulate AC. A
ligand for GPR30 has not been identified yet, however, may
be a certain peptide or glycoprotein (Carmeci et al, 1997).
GPR30 mRNA is ubiquitously expressed in the brain, lung,
liver, prostate, or colon (Owman et al, 1996). Thus GPR30-
mediated cyclin D2 expression and growth-stimulation may
generally occur in a variety of tissues, and this possibility
should further be examined.
CREB can be phosphorylated at Ser133 by serine/
threonine kinases different from PKA (Tan et al, 1996). E2
induced CREB phosphorylation by activating PI-3K/Akt
pathway in rat cortical neurons (Honda et al, 2001). But the
activation of PI-3K/Akt pathway by E2 is rather unlikely in
keratinocytes lacking ERa, since PI-3K is activated by E2-
bound ERa but not by ERb (Simoncini et al, 2000). In the cell
types other than keratinocytes, E2 induced intracellular
Ca2þ signal (Benten et al, 2001), activated phospholipase
C/protein kinase C pathway (Le Mellay et al, 1999) or src/
Ras/ERK kinase/ERK pathway (Migliaccio et al, 1996), all
of which are relevant to CREB phosphorylation. But in
keratinocytes, these E2-induced signals may not occur, or
may be insufficient, if any, for CREB-mediated cyclin D2
transcription, possibly because the magnitude of the signals
may be small and/or their duration may be short.
Previous studies reported that cAMP regulated the
growth of keratinocytes dependent on its concentration;
low level (106 or 105 M) of dibutyryl cAMP stimulates,
whereas high level (103 M) inhibits DNA replication or
proliferation (Falanga et al, 1991; Onuma et al, 2001). The
growth-inhibition by high level of cAMP may be related to
the induction of p27Kip1, which inactivates cyclin D-Cdk4
complexes. In murine macrophages, 103 M of dibutyryl
cAMP increased the level of p27Kip1, which counteracted
the pRb-phosphorylating activity of cyclin D-Cdk4 com-
plexes and induced G1 phase arrest (Kato et al, 1994). They
suggested that the cell growth may be regulated by the
relative expression of D-type cyclins and p27Kip1. Robker
and Richards (1998) also suggested that low level of cAMP,
e.g., FSH stimulus, may enhance the proliferation of
granulosa cells by increasing cyclin D2 level without
inducing p27Kip1, whereas high level of cAMP, e.g., LH
surge, may increase the level of p27Kip1, exceeding the
effect of cyclin D2, and may totally inhibit the proliferation. It
is thus hypothesized that the threshold of cAMP for p27Kip1
induction may be higher than that for cyclin D2. In human
keratinocytes, E2 did not increase p27Kip1 mRNA (Fig 3) or
protein levels (data not shown) at various concentrations
ranging from 1012 to 106 M. In our previous study, E2
increased intracellular cAMP concentration maximally 4–5
fold of the basal level in human keratinocytes (Kanda and
Figure 10
Inhibition by GPR30 antisense oligonucleotide on E2-induced
increases in phosphorylated CREB (a), cyclin D2 protein level (b),
BrdU incorporation (c), and proliferation (d). Keratinocytes were
pretreated with 0.2 mM of indicated antisense oligonucleotides (ASO) or
control scrambled oligonucleotides (Con) for 4 h. The cells were then
incubated with 108 M E2. EMSA was performed at 1 h (a) using
antibody against phosphorylated CREB (P). Cyclin D2 protein level was
evaluated at 3 h (b), BrdU incorporation was analyzed at 24 h (c), and
cell number was counted after 4 d (d). The results shown in (a, b) are
representative of five separate experiments. In (c, d), values are
mean  SEM of five separate experiments. po0.05 versus values
with medium alone, wpo0.05 versus values with E2 alone, by one-way
ANOVA with Scheffe’s multiple comparison test.
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Watanabe, 2003b), which may be insufficient for the
induction of p27Kip1.
In this study, E2 directly stimulated the growth of
keratinocytes via cyclin D2. To date, fibroblasts have been
thought as a main target of E2 in the skin; E2 induces
fibroblasts to synthesize extracellular matrix by promoting
TGF-b1 production, which was considered as the main
mechanism for the increase of skin thickness by E2 (Shah
and Maibach, 2001). Our present results, however, suggest
that another possible mechanism is the direct growth-
stimulation on keratinocytes. E2 may thus prevent or delay
age-associated epidermal atrophy by inducing cyclin D2
expression in keratinocytes. Our results also suggest that
E2 may promote re-epithelialization in the wound. It is
reported that E2 accelerates cutaneous wound healing
(Ashcroft et al, 1997). We also recently found that E2
induced human macrophages to produce nerve growth
factor, a cytokine that enhances proliferation of keratino-
cytes (Kanda and Watanabe, in press (b)). Taken together,
E2 may promote re-epithelialization in the wound via both
direct growth-stimulation on keratinocytes and indirect
mechanism through accessory cells. Re-epithelialization in
the wound is delayed in aged skin (Xia et al, 2001), which
may be partially due to the age-associated reduction of
growth potential in keratinocytes (Gilchrest and Taar, 1992;
Varani et al, 1998). Topical application of E2 may thus be
therapeutically useful for the delayed wound healing in the
aged skin.
Materials and Methods
Reagents E2, 17b-estradiol 6-(O-carboxymethyl)oxime:bovine
serum albumin (E2-BSA), 17a-estradiol, and 4-hydroxytamoxifen
were purchased from Sigma (St Louis, Missouri). ICI 182,780 was
from Wako Pure Chemical Industries (Osaka, Japan). LY294002,
calphostin C, rapamycin, W-7, PD98059, SB202190, and N-[2-
((p-bromociannamyl)amino)ethyl]-5-isoquinolinesulfonamide (H-89)
were obtained from Calbiochem (La Jolla, California). Monoclonal
antibodies against cAMP response element (CRE) binding pro-
tein (CREB) and Ser133-phosphorylated CREB were purchased
from New England Biolabs (Beverly, Massachusetts). Antibodies
against human cyclin D1, cyclin D2, cyclin D3, Cdk4, and Cdk6
were from Santa Cruz Biotechnology (Santa Cruz, California). Anti-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) monoclonal
antibody was from American Research Products (Belmont,
Massachusetts).
Culture of keratinocytes Normal human keratinocytes from sun-
protected, disease-free chest skin of a 70-y-old Caucasian woman
(Clonetics, Walkersville, Maryland) were cultured in serum-free
KGM medium (Clonetics) consisting of basal medium MCDB153
supplemented with 0.5 mg mL hydrocortisone, 5 ng per mL
epidermal growth factor, 5 mg per mL insulin, and 0.5% bovine
pituitary extract. The cells in the third passage were used.
Measurement of bromodeoxyuridine (BrdU) incorporation and
proliferation of keratinocytes BrdU incorporation was measured
by ELISA using the BrdU Labeling and Detection Kit (Roche,
Indianapolis, Indiana) according to the manufacturer’s instruction.
Keratinocytes (5  103 per well) were seeded in triplicate into 96-
well plates in 100 mL KGM, adhered for 8 h, then the medium was
changed to phenol red-free, basal KBM depleted of growth
supplements, and incubated for 18 h. The medium was removed
and the cells were incubated with indicated hormones in phenol
red-free KBM for 20 h. The cells were then incubated with 10 mM
BrdU for another 4 h. Cells were subjected to immunostaining with
anti-BrdU monoclonal antibody. BrdU incorporation was evaluated
by the absorbance at 405 nm minus that at 492 nm. In parallel
experiments, keratinocytes were seeded at 1  104 cells per well
into 24-well plates, adhered for 8 h, starved for 18 h, then re-fed
with fresh phenol red-free KBM including hormones. After 4 d, the
cells were harvested, and total cell number was counted using a
hemocytometer.
Cell cycle analysis Keratinocytes were incubated with hormones
for 24 h as above, then harvested and suspended in 0.1% sodium
citrate and 0.1% Triton-X-100 containing 50 mg per mL propidium
iodide and 1 mg per mL RNase (Calbiochem) for 30 min. DNA
fluorescence was measured with a FACScan flow cytometer
(Becton Dickinson, San Diego, California), and the percentages
of cells within G0/G1, S, and G2/M phases of the cell cycle were
determined as described (van Ruissen et al, 1994).
RT-PCR Keratinocytes were incubated as above, then the total
cellular RNA was extracted using TRIzol reagent (Invitrogen,
Rockville, Maryland). We reverse transcribed 0.5 mg of total RNA
to produce cDNA as described (Tjandrawinata et al, 1997), and 1/
30 of synthesized cDNA was thermocycled for PCR amplification
with 1 mM each primer and 1.5 U of Taq polymerase (Invitrogen).
Primers for amplification and the sizes of respective PCR products
were as follows: cyclin D1, 50-AGGAGAACAAACAGATCA-30 and
50-TAGGACAGGAAGTTGTTG-30 for 162 bp; cyclin D2, TCAT-
GACTTCATTGAGCA-30 and 50-CACTTCCTCATCCTGCTG-30 for
195 bp; cyclin D3, 50-ACATGATTTCCTGGCCTT-30 and 50-
TGAGCTCATCCCCGGACA-30for 220 bp; p16INK4A, 50-AGCAG-
CATGGAGCCTTCGGC-30 and 50-CTCTCTGGTTCTTTCAATCG-30
for 475 bp; p21Cip1, 50-ACAGCAGAGGAAGACCATGT-30 and 50-
GGTATGTACATGAGGAGGTG-30 for 319 bp; p27Kip1, TGCAGAGA-
CATGGAAGAGGC-30 and CGTTTGACGTCTTCTGAGGC-30 for
449 bp; GAPDH, 50-GCAGGGGGGAGCCAAAAGGG-30 and 50-
TGCCAGCCCCAGCGTCAAAG-30 for 566 bp (Scwaller et al, 1997;
Yu et al, 2002; Kanda and Watanabe, 2003a). PCR was performed
by one denaturing cycle of 951C for 3 min, 25 cycles of
denaturation at 951C for 30 s, annealing at 581C for 30 s, and
extension at 721C for 30 s, and a final extension at 721C for 3 min.
In preliminary experiments, 25 cycles lay in the exponential phase
of amplification for each gene examined. The PCR products were
analyzed by electrophoresis on 2.5% agarose gels and stained
with ethidium bromide, viewed by UV light. Densitometric analysis
of the bands was performed by NIH Image Software (http://
rsb.info.nih.gov/nih-image/). The mRNA levels of D-type cyclins or
Cdk inhibitors were normalized for that of GAPDH.
Western blot analysis Keratinocytes incubated under the indi-
cated conditions were lysed and centrifuged as described (Kanda
and Watanabe, 2002). Protein concentration in the supernatant
was determined by BioRad DC reagent (Bio-Rad Laboratories,
Hercules, California). For western analysis, 20 mg of proteins were
resolved on a 10% SDS-polyacrylamide gel. The proteins were
transferred onto a PVDF membrane. The membrane was blocked,
and exposed to primary antibodies, followed by peroxidase-
conjugated secondary antibodies (Bio-Rad). The blots were
developed with an enhanced chemiluminescence kit (Amersham,
Arlington Heights, Illinois). Densitometric analysis of the bands was
performed by NIH Image Software.
Kinase assays In vitro kinase assay was performed in immuno-
precipitates with antibodies against cyclin D2, cyclin D3, Cdk4, or
Cdk6. Keratinocytes were lysed in lysis buffer (50 mM Hepes, 150
mM NaCl, 10% glycerol, 1% Triton-X, 1.5 mM MgCl2, 1 mM EGTA,
100 mM NaF, 500 mM Na3VO4, 10 mg per mL aprotinin, 10 mg per
mL leupeptin, and 1 mM PMSF). Two hundred micrograms of the
lysates were immunoprecipitated with various antibodies using
Sepharose G beads (Pharmacia, Uppsala, Sweden), washed four
times with lysis buffer, then washed twice with kinase buffer (80
mM sodium b-glycerophosphate, pH 7.4, 20 mM EGTA, 15 mM
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Mg(OAc)2, and 1 mM dithiothreitol), and then mixed with 10 mL
kinase buffer containing 50 mM ATP, 1.25 mCi[a-32P]ATP, and 1 mg
glutathione S-transferase-retinoblastoma protein (GST-pRb). The
samples were incubated at 301C for 30 min and the reactions were
terminated by addition of 30 mL Laemli sample buffer. The samples
were separated on 10% SDS-polyacrylamide gel and visualized by
autoradiography. In parallel experiments, the immunoprecipitates
with anti-Cdk4 or Cdk6 antibodies were immunoblotted with anti-
cyclin D2 or cyclin D3 antibodies, and developed.
Plasmids and transfections The firefly luciferase reporter plas-
mid driven by human cyclin D2 promoter (1624/1 bp relative to
the translational start site) was constructed by PCR and insertion
into pGL3 basic vector (Promega, Madison, Wisconsin) as
described (Ohtani et al, 2000), and was denoted as pCycD2-Luc.
Site-specific mutation of the promoter was created by multiple
rounds of PCR using primers with altered bases as described
(Huang et al, 2001). The sequences of these mutants are; E2F site:
GCGCGAAA to GCATGAAA, NF-kB-like element 1: GAAGAGCC-
CCC to GAAGAGGTTCC, NF-kB-like element 2: CGGGGCTTTCG
to CGAACCTTTCG, CRE-like element: TTGCGTCA to TTGCGCAG,
NF-kB-like element 3: CGAAAACCCCC to CGAAAAATTCC, and
NF-kB-like element 4: AGAAAAACCCT to AGAACAGTTCT.
p4xCRE-TATA-Luc was constructed by inserting four copies of
CRE-like element (50-CCAGCTTGCGTCACCGCT-30) from cyclin
D2 promoter in front of TATA box upstream of firefly luciferase
reporter as described (Kanda and Watanabe, 2003a). Transient
transfections were performed with Effectene (Qiagen, Tokyo,
Japan) as described (Zellmer et al, 2001). The efficiency of
transfection into keratinocytes by this method was mean  SEM
28.5  3.1% (n¼ 9) as determined by flow cytometry using b-
galactosidase vector. Keratinocytes were plated in 10-cm dishes
and grown to about 60% confluence. Twenty-four hours before the
transfection, the medium was changed to phenol red-free KBM.
Keratinocytes were incubated for 6 h with 5 mg of pCycD2-Luc or
p4xCRE-TATA-Luc and 1 mg of SV40 promoter-linked b-galactosi-
dase reporter vector, pCH110 (Amersham), premixed with en-
hancer, transfection buffer, and Effectene. The transfected cells
were washed and incubated in fresh phenol red-free KBM for 18 h,
then incubated with indicated hormones. After 5 h, cell extracts
were prepared and luciferase activities were quantified using
luciferase assay system (Promega). The same cell extracts were
assayed for b-galactosidase activity using chemiluminescent
Galacto-Light kit (Tropix, Bedford, Massachusetts). All readings
were taken using a Lumat 9501 luminometer (Berthold, Wildbach,
Germany). The results obtained in each transfection were normal-
ized for b-galactosidase activity and expressed as relative
luciferase activity. In our preliminary experiments, E2 did not alter
the control b-galactosidase activity (data not shown).
Electrophoretic mobility shift assay (EMSA) EMSA was per-
formed as described (Huang et al, 2001). The probe used was 32P-
labelled annealed double-stranded DNA containing CRE-like
element from human cyclin D2 promoter: CCAGCCAGCTTGCGT-
CACCGCTTCAGA. For EMSA, 2–5 mg of nuclear protein extracts
were incubated at room temperature for 5 min with a mixture
containing 6 mM Hepes (pH 7.9), 0.4 mM EDTA, 125 mM KCl, 10%
glycerol, 0.05 mg per mL poly dI–dC, 1 mM DTT, 2.5 mM sodium
pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na3VO4, 10 mM
NaF, 50 mg per mL aprotinin, 50 mg per mL leupeptin. One
nanogram of labeled probe was added and the reactions were
incubated for another 20 min. In antibody supershift experiments,
the nuclear extracts were pre-incubated with antibodies against
CREB or Ser133-phosphorylated CREB for 30 min before the
addition of probe. Reactions were then fractionated on a
nondenaturing 5% polyacrylamide gel, and visualized with phos-
phorimager (Molecular Dynamics, Sunnyvale, California).
Treatment with antisense oligodeoxynucleotides Antisense
oligonucleotides were synthesized as described (Lau et al, 2000;
O’Dowd et al, 1998; Wu et al, 1995). The oligonucleotides were
ERb, 50-CATCACAGCAGGGCTATA-30; GPR30, 50-TTGGGAAGT-
CACATCCAT-30; cyclin D2, 50-ACAGCAGCTCCATGGCCAG-30;
random control, 50-GATCTCAGCACGGCAAAT-30. For antisense
experiments, keratinocytes were washed twice in phosphate-
buffered saline, then transfected finally with 0.2 mM of the indicated
oligonucleotides premixed with Superfect Reagent (Qiagen) in
phenol red-free KBM for 4 h. The medium was aspirated and fresh
medium containing E2 was added.
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